Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
about
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implicationsA high susceptibility to redox imbalance of the transmissible stages of Plasmodium falciparum revealed with a luciferase-based mature gametocyte assayRepositioning: the fast track to new anti-malarial medicines?Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain.Glucose-6-phosphate dehydrogenase deficiency among children attending the Emergency Paediatric Unit of Usmanu Danfodiyo University Teaching Hospital, Sokoto, NigeriaModeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination.Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.PharmGKB summary: methylene blue pathway.Verapamil-Sensitive Transport of Quinacrine and Methylene Blue via the Plasmodium falciparum Chloroquine Resistance Transporter Reduces the Parasite's Susceptibility to these Tricyclic Drugs.Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?Drugs that reduce transmission of falciparum malaria.Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.Diagnosis and Treatment of Plasmodium vivax Malaria.Methylene blue for treating malaria
P2860
Q27005605-131DBF7D-AE51-445D-9336-549939D71159Q30044470-15CC05D4-3739-4759-B84B-87152EE85C9CQ33612012-D833D760-5D20-4010-AB3D-E1A083B81416Q35701564-DFA7EA37-4323-4917-8852-523A385344C3Q36785808-AD09DD69-E35E-4287-905D-9D650CFF6223Q37014069-B4F876E8-9068-46B8-BFBF-C94B69D06147Q37509562-57001692-3D27-4950-9C8D-12022C918A0CQ38245842-B9DE82A7-EDD1-416B-8DFB-909C72569BF8Q41890556-D192B6D1-C12B-4D77-8512-130766F640EAQ41916522-795F4A72-5CD8-46F3-B845-1EA887CC61C5Q46179000-B9033C2E-53F9-4C44-A980-4EF5A2279F59Q50107879-2747CE71-737A-435C-8BC2-A2BBA36DD964Q50107885-1D1C9656-AABB-4A85-AE0A-5376700EE2A3Q52565814-0FD7AC9F-E4B6-43B6-BDC3-AD14D0934B77Q53696257-80956355-CD89-441C-947F-9EC3B63ECF28Q53767337-03807D97-C1C3-412E-B965-76D17C45EDC1Q56785617-9BFA159A-533E-4FCD-AEA4-0A0FCDE96328
P2860
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@en
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@nl
type
label
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@en
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@nl
prefLabel
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@en
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@nl
P2093
P2860
P356
P1476
Haemolysis risk in methylene b ...... aria: a synopsis of four RCTs.
@en
P2093
Bernd Marks
Boubacar Coulibaly
Hannes Buchner
Ingeborg Walter-Sack
Olaf Müller
Peter Meissner
R Heiner Schirmer
Ronny Kuhnert
Ulrich Mansmann
P2860
P304
P356
10.1002/PDS.3370
P577
2012-11-07T00:00:00Z